IPPRA / Grant Monitor

2026-07-07
← Board

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

RFA-DA-25-024 · National Institutes of Health

biomedical clinical public health mental behavioral health social services Education Health

Closes
2027-03-06 · 242 d
Award ceiling
Award floor
Program funding
Expected awards
Cost sharing
No
Posted
2024-08-02
Instrument
Grant
Characterization · gpt-5.4-mini · 2026-07-07

NIH funds R01 research projects on the intersection of HIV and substance use, with a required HIV/AIDS priorities nexus and preliminary data, for eligible institutions and organizations including universities.

Funds
basic research
University
direct
social behavioral
substantial
physical sciences
minor
engineering
minor
life biomedical
central
computational data
minor

⚑ Clinical Trial Optional · Requires clear nexus with substance use and alignment to NIH HIV/AIDS Research Priorities · Preliminary data required · Open to a wide range of applicant organizations, including foreign organizations and many MSI/tribal/community-based classes

Unit fits — one characterization, each unit's own rules

IPPRA 58 good peripheral portfolio topic: public_health; signature methods: community engaged, policy analysis; social/behavioral work is substantial; funds basic research; biomedical core — IPPRA health lane is communication/crisis/policy (capped); clinical-trial/biomedical core — IPPRA angle is policy/community (capped)
Physical Sciences & Engineering (demo) 55 good technical depth: minor; funds basic research
Tom Love Innovation Hub 15 none deep-tech content; no commercialization signal

Description

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Eligibility

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Apply

View on Grants.gov → CONTACT: National Institutes of Health <grantsinfo@nih.gov>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · National Institutes of Health conventions SEE AN NIH EXAMPLE →

Funder-faithful document skeletons — National Institutes of Health's document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING